I agree it is unlikely. However, there would b
Post# of 148175
(Total Views: 465)
Posted On: 10/23/2020 2:28:53 PM
Re: ClosetInvestor #62945
I agree it is unlikely.
However, there would be a public record of the interim results and give CYDY way more leverage in possibile negotiations with BARDA and OWS (if that was ever a topic).
Can get them another spot on FOX Business or whatever: "Our interim results are very encouraging and suggest a 50% mortality reduction. Unfortunately, our NIH only tests toxic turd drugs with marginal efficacy or sets up the 100th trial of overdosed hydroxychloroquine and does open-label studies for plasma therapy that allows no conclusion whatsoever regarding its efficacy. Also, OWS and BARDA like to throw hundreds of millions to BP and vaccine companies that haven't accomplished anything in 30 years. Our trial sites are in x y z, we need more patients to fill our trial and definitely prove efficacy. We take a $50m cheque at any time".
LOL
However, there would be a public record of the interim results and give CYDY way more leverage in possibile negotiations with BARDA and OWS (if that was ever a topic).
Can get them another spot on FOX Business or whatever: "Our interim results are very encouraging and suggest a 50% mortality reduction. Unfortunately, our NIH only tests toxic turd drugs with marginal efficacy or sets up the 100th trial of overdosed hydroxychloroquine and does open-label studies for plasma therapy that allows no conclusion whatsoever regarding its efficacy. Also, OWS and BARDA like to throw hundreds of millions to BP and vaccine companies that haven't accomplished anything in 30 years. Our trial sites are in x y z, we need more patients to fill our trial and definitely prove efficacy. We take a $50m cheque at any time".
LOL
(7)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼